Department of Radiology, Mayo Clinic Florida, Jacksonville, FL, USA.
Department of Biostatistics, Mayo Clinic Florida, Jacksonville, FL, USA.
Ann Surg Oncol. 2022 Jun;29(6):3839-3848. doi: 10.1245/s10434-022-11476-6. Epub 2022 Mar 8.
Preoperative breast MRI is indicated for staging but can lead to complex imaging workups. This study reviewed imaging recommendations made on preoperative MRI exams, to simplify management approaches for patients with newly diagnosed breast cancer.
This retrospective single-institution review was restricted to women with breast cancer who underwent staging MRI. Additional breast lesions, separate from index tumors, recommended for additional workup or surveillance were assessed to see which were detected and which characteristics predicted success in detection. Univariate mixed-effects logistic modeling predicted the likelihood of finding lesions using MRI-directed ultrasound (US), with odds ratios reported. Tests were two-sided, with a p value lower than 0.05 considered significant.
In this study, 534 (39.6%) patients had recommendations for additional workup after preoperative MRI. MRI detected additional malignancy in 178 patients (33.3%). Half of the 66 patients who refused an additional workup and opted for mastectomy had additional malignancies at mastectomy. MRI-directed US was 14 times more likely to detect masses than nonmass enhancement (NME) (p < 0.001). NME was detected on US in only 16% of cases, with one third of subsequent biopsy results considered discordant. Probably benign assessments were given to 35 patients, with 23% not returning for follow-up evaluation and 7% returning at least 6 months later than recommended.
Use of preoperative breast MRI has increased. Although it can add value, institutions should establish indications and expectations to prevent unnecessary workups. Limiting MRI-directed US to masses, avoiding probably benign assessments, and consulting with patients after MRI but prior to workups can prevent unnecessary exams and confusion.
术前乳腺 MRI 用于分期,但可能导致复杂的影像学检查。本研究回顾了术前 MRI 检查中的影像学建议,以简化新诊断乳腺癌患者的管理方法。
本回顾性单机构研究仅限于接受分期 MRI 的乳腺癌女性。评估了与索引肿瘤分开的额外乳腺病变,建议进行额外的检查或监测,以确定哪些病变被检测到,以及哪些特征预测检测的成功。使用多变量混合效应逻辑模型预测 MRI 引导下超声 (US) 检测病变的可能性,报告比值比。检验为双侧,p 值低于 0.05 认为有统计学意义。
在这项研究中,534 名(39.6%)患者在术前 MRI 后有进一步检查的建议。MRI 在 178 名患者中发现了额外的恶性肿瘤(33.3%)。66 名拒绝进一步检查并选择乳房切除术的患者中有一半在乳房切除术中发现了额外的恶性肿瘤。MRI 引导下 US 检测肿块的可能性是检测非肿块强化(NME)的 14 倍(p < 0.001)。NME 在 US 上仅检测到 16%,其中三分之一的后续活检结果被认为不一致。35 名患者被评估为可能良性,其中 23%未进行随访评估,7%在推荐的随访时间后至少 6 个月才进行。
术前乳腺 MRI 的使用有所增加。尽管它可以增加价值,但医疗机构应确定适应证和预期,以防止不必要的检查。将 MRI 引导下 US 限制在肿块上,避免可能良性的评估,以及在 MRI 后但在检查前与患者协商,可以防止不必要的检查和混淆。